FWIA
AKBA icon

Fort Washington Investment Advisors’s Akebia Therapeutics AKBA Stock Holding History

Fort Washington Investment Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-94,000
Closed -$908K – 382
2015
Q3 		$908K Hold
94,000
– – 0.02% 293
2015
Q2 		$967K Hold
94,000
– – 0.02% 283
2015
Q1 		$1.04M Hold
94,000
– – 0.02% 273
2014
Q4 		$1.09M Sell
94,000
-16,000
-15% -$229K 0.02% 263
2014
Q3 		$2.43M Buy
+110,000
New +$2.53M 0.05% 196

Other funds holding AKBA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Fort Washington Investment Advisors's AKBA Position: Q4 2015 in Review

Fort Washington Investment Advisors sold out of Akebia Therapeutics (AKBA) in Q4 2015, closing a stake of 94,000 shares — an estimated $908K sold.

Fort Washington Investment Advisors first reported a position in AKBA in Q3 2014 and held it in 5 quarters. The position peaked at $2.43M in Q3 2014. 91 funds tracked by Wall St. Rank hold AKBA as of Q4 2015.

  • Fort Washington Investment Advisors reported no remaining Akebia Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 94,000 Akebia Therapeutics shares in Q4 2015, an estimated $908K.
  • Fort Washington Investment Advisors first reported a position in Akebia Therapeutics in Q3 2014 and held it in 5 quarters.
  • Fort Washington Investment Advisors's Akebia Therapeutics position peaked at $2.43M in Q3 2014.
  • 91 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2015.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.